StonvexLoading…
StonvexStonvexStonvexCore line items from FCN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $983.35M | $3.79B | $2.80B | $1.84B |
Operating Income | $83.92M | $389.08M | $295.64M | $177.97M |
Net Income | $57.63M | $270.87M | $216.34M | $71.70M |
EPS (Diluted) | $1.90 | $8.24 | $6.43 | $3.87 |
Total Assets | $3.51B | $3.49B | $3.49B | $3.49B |
Total Liabilities | $1.84B | $1.76B | $1.74B | $1.59B |
Cash & Equivalents | $198.28M | $265.09M | $145.97M | $152.83M |
Free Cash Flow OCF − CapEx | $-320.64M | $93.60M | $-257.77M | $-444.75M |
Shares Outstanding | 30.14M | 30.86M | 31.35M | 32.73M |